Christopher Alan Moxon

Christopher Alan Moxon

Auto-generated profile, based on publicly available information

Christopher Alan Moxon

School of Infection and Immunity, MVLS, University of Glasgow; Glasgow, G12 8TA, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Blood
Verified
Journal Article
Open access
PDF file
CMChristopher A. Moxon
Christopher A. Moxon
SWSamuel C. Wassmer
Samuel C. Wassmer
DMDanny A Milner
Danny A Milner
NCNgawina V. Chisala
Ngawina V. Chisala
TTTerrie E. Taylor
Terrie E. Taylor
RHRobert Heyderman
Robert Heyderman
Key Points: In cerebral malaria, IEs cause loss of protein C receptors and a highly localized microvascular coagulopathy. Low cerebral constitutive expression of these receptors, EPCR and TM, may explain the brain's vulnerability to IE-dependent pathology.

24 January 2020 in Annual Review of Pathology: Mechanisms of Disease
Verified
Journal Article
Open access
CMChristopher A. Moxon
Christopher A. Moxon
MGMatthew P. Gibbins
Matthew P. Gibbins
DMDagmara McGuinness
Dagmara McGuinness
DMDanny A. Milner
Danny A. Milner
MMMatthias Marti
Matthias Marti
Malaria remains a major public health threat in tropical and subtropical regions across the world. Even though less than 1% of malaria infections are fatal, this leads to about 430,000 deaths per year, predominantly in young children in sub-Saharan Africa. Therefore, it is imperative to understand why a subset of infected individuals develop severe syndromes and some of them die and what differentiates these cases from the majority that recovers. Here, we discuss progress made during the past decade in our understanding of malaria pathogenesis, focusing on the major human parasite Plasmodium falciparum.

11 October 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
SKSebastian Lorenz Knackstedt
Sebastian Lorenz Knackstedt
AGAthina Georgiadou
Athina Georgiadou
FAFalko Apel
Falko Apel
UAUlrike Abu-Abed
Ulrike Abu-Abed
CMChristopher A. Moxon
Christopher A. Moxon
BABorko Amulic
Borko Amulic
NETs contribute to malaria by promoting emergency granulopoiesis and endothelial binding of parasitized erythrocytes.

4 January 2019 in EMBO Molecular Medicine
Verified
Journal Article
Open access
JSJanet Storm
Janet Storm
JJJakob S Jespersen
Jakob S Jespersen
KSKarl B Seydel
Karl B Seydel
TSTadge Szestak
Tadge Szestak
MMMaurice Mbewe
Maurice Mbewe
ACAlister G Craig
Alister G Craig
Sequestration of Plasmodium falciparum ‐infected erythrocytes (IE) within the brain microvasculature is a hallmark of cerebral malaria (CM). Using a microchannel flow adhesion assay with TNF‐activated primary human microvascular endothelial cells, we demonstrate that IE isolated from Malawian paediatric CM cases showed increased binding to brain microvascular endothelial cells compared to IE from uncomplicated malaria (UM) cases. Further, UM isolates showed significantly greater adhesion to dermal than to brain microvascular endothelial cells. The major mediator of parasite adhesion is P. falciparum erythrocyte membrane protein 1, encoded by var genes. Higher levels of var gene transcripts predicted to bind host endothelial protein C receptor (EPCR) and ICAM‐1 were detected in CM isolates. These data provide further evidence for differential tissue binding in severe and uncomplicated malaria syndromes, and give additional support to the hypothesis that CM pathology is based on increased cytoadherence of IE in the brain microvasculature.

28 May 2011 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
CMChristopher A. Moxon
Christopher A. Moxon
Georges Emile GrauGeorges Emile Grau
Georges Emile Grau
ACAlister G. Craig
Alister G. Craig
Summary: Residence in the human erythrocyte is essential for the lifecycle of all Plasmodium that infect man. It is also the phase of the life cycle that causes disease. Although the red blood cell (RBC) is a highly specialized cell for its function of carrying oxygen to and carbon dioxide away from tissues, it is devoid of organelles and lacks any cellular machinery to synthesize new protein. Therefore in order to be able to survive and multiply within the RBC membrane the parasite needs to make many modifications to the infected RBC (iRBC). Plasmodium falciparum (P. falciparum) also expresses parasite‐derived proteins on the surface of the iRBC that enable the parasite to cytoadhere to endothelial and other intravascular cells. These RBC modifications are at the root of malaria pathogenesis and, in this ancient disease of man, have formed the epicentre of a genetic ‘battle’ between parasite and host. This review discusses some of the critical modifications of the RBC by the parasite and some of the consequences of these adaptations on disease in the human host, with an emphasis on advances in understanding of the pathogenesis of severe and cerebral malaria (CM) from recent research.

1 July 2019 in The Lancet Respiratory Medicine
Verified
Journal Article
Open access
MLMichael Levin
Michael Levin
ACAubrey J Cunnington
Aubrey J Cunnington
CWClare Wilson
Clare Wilson
SNSimon Nadel
Simon Nadel
HLHans Joerg Lang
Hans Joerg Lang
CHClive J Hoggart
Clive J Hoggart
Fluid resuscitation is the recommended management of shock, but increased mortality in febrile African children in the FEAST trial. We hypothesised that fluid bolus-induced deaths in FEAST would be associated with detectable changes in cardiovascular, neurological, or respiratory function, oxygen carrying capacity, and blood biochemistry. We developed composite scores for respiratory, cardiovascular, and neurological function using vital sign data from the FEAST trial, and used them to compare participants from FEAST with those from four other cohorts and to identify differences between the bolus (n=2097) and no bolus (n=1044) groups of FEAST. We calculated the odds of adverse outcome for each ten-unit increase in baseline score using logistic regression for each cohort. Within FEAST participants, we also compared haemoglobin and plasma biochemistry between bolus and non-bolus patients, assessed the effects of these factors along with the vital sign scores on the contribution of bolus to mortality using Cox proportional hazard models, and used Bayesian clustering to identify subgroups that differed in response to bolus. The FEAST trial is registered with ISRCTN, number ISRCTN69856593. Increasing respiratory (odds ratio 1·09, 95% CI 1·07-1·11), neurological (1·26, 1·21-1·31), and cardiovascular scores (1·09, 1·05-1·14) were associated with death in FEAST (all p<0·0001), and with adverse outcomes for specific scores in the four other cohorts. In FEAST, fluid bolus increased respiratory and neurological scores and decreased cardiovascular score at 1 h after commencement of the infusion. Fluid bolus recipients had mean 0·33 g/dL (95% CI 0·20-0·46) reduction in haemoglobin concentration after 8 h (p<0·0001), and at 24 h had a decrease of 1·41 mEq/L (95% CI 0·76-2·06; p=0·0002) in mean base excess and increase of 1·65 mmol/L (0·47-2·8; p=0·0070) in mean chloride, and a decrease of 0·96 mmol/L (0·45 to 1·47; p=0·0003) in bicarbonate. There were similar effects of fluid bolus in three patient subgroups, identified on the basis of their baseline characteristics. Hyperchloraemic acidosis and respiratory and neurological dysfunction induced by saline or albumin bolus explained the excess mortality due to bolus in Cox survival models. In the resuscitation of febrile children, albumin and saline boluses can cause respiratory and neurological dysfunction, hyperchloraemic acidosis, and reduction in haemoglobin concentration. The findings support the notion that fluid resuscitation with unbuffered electrolyte solutions may cause harm and their use should be cautioned. The effects of lower volumes of buffered solutions should be evaluated further. Medical Research Council, Department for International Development, National Institute for Health Research, Imperial College Biomedical Research Centre.